Molecular structure of Levomefolic Acid
Levomefolic Acid (CAS 31690-09-2)
Alternate Names:
N-[4-[[[(6S)-2-Amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-L-glutamic Acid
CAS Number:
31690-09-2
Molecular Weight:
459.46
Molecular Formula:
C20H25N7O6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Levomefolic acid is a compound that has garnered attention in biochemical studies due to its role as a biologically active form of folate. It is involved in one-carbon metabolism, where it plays a key role in the synthesis of nucleic acids and the methylation of DNA, proteins, and lipids. Studies involving levomefolic acid focus on understanding its influence on cellular processes such as gene expression and its involvement in the homocysteine cycle. In the field of nutrigenomics, levomefolic acid is of interest for its impact on health-related genetic expression. Levomefolic acid is used to investigate the biochemical pathways that are influenced by folate status and to explore how these pathways affect cellular function.
Levomefolic Acid (CAS 31690-09-2) References
- Safe management of a bipolar depressed patient with prefrontal repetitive transcranial magnetic stimulation (rTMS) Over 7 years and >2 million stimuli. | Li, X., et al. 2014. Brain Stimul. 7: 919-21. PMID: 25440291
- Meta-analysis study to evaluate the association of MTHFR C677T polymorphism with risk of ischemic stroke. | Abhinand, PA., et al. 2017. Bioinformation. 13: 214-219. PMID: 28729765
- The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. | Firth, J., et al. 2019. World Psychiatry. 18: 308-324. PMID: 31496103
- Large-scale metabolic interaction network of the mouse and human gut microbiota. | Lim, R., et al. 2020. Sci Data. 7: 204. PMID: 32591517
- Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. | Prajapat, M., et al. 2020. J Mol Graph Model. 101: 107716. PMID: 32866780
- Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs. | Kouznetsova, VL., et al. 2020. PeerJ. 8: e9965. PMID: 32999768
- Case Report of Dual-Site Neurostimulation and Chronic Recording of Cortico-Striatal Circuitry in a Patient With Treatment Refractory Obsessive Compulsive Disorder. | Olsen, ST., et al. 2020. Front Hum Neurosci. 14: 569973. PMID: 33192400
- Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19. | Baby, K., et al. 2020. F1000Res. 9: 1166. PMID: 33204411
- Serum Folate, Vitamin B12 Levels, and Systemic Immune-Inflammation Index Correlate With Motor Performance in Parkinson's Disease: A Cross-Sectional Study. | Li, S., et al. 2021. Front Neurol. 12: 665075. PMID: 34093411
- A hydrated 2,3-diaminophenazinium chloride as a promising building block against SARS-CoV-2. | Mahato, RK., et al. 2021. Sci Rep. 11: 23122. PMID: 34848758
- Detection of Mycotoxins in Highly Matrix-Loaded House-Dust Samples by QTOF-HRMS, IM-QTOF-HRMS, and TQMS: Advantages and Disadvantages. | Lindemann, V., et al. 2022. Anal Chem. 94: 4209-4217. PMID: 35231175
- In silico anti-SARS-CoV-2 activities of five-membered heterocycle-substituted benzimidazoles. | Mudi, PK., et al. 2022. J Mol Struct. 1261: 132869. PMID: 35340531
- In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs. | Chan, WKB., et al. 2022. Sci Rep. 12: 5320. PMID: 35351926
- BabyBoom: 3-Dimensional Structure-Based Ligand and Protein Interaction Prediction by Molecular Docking. | Panchangam, SS. 2022. Biomolecules. 12: PMID: 36358982
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Levomefolic Acid, 5 mg | sc-489379 | 5 mg | $411.00 |